Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Foung
Paul Foung, North Brunswick, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20110045683 | CONNECTOR LOCKING DEVICE - Embodiments of the present invention relate to a connector locking device for network cables and methods of utilizing the same. In one embodiment of the present invention, a self-releasing connector locking device comprises a locking tongue support for supporting a locking tongue of a connector, a first retaining mechanism for engaging a portion of a body of a terminal, and a first release arm for releasing the retaining mechanism from the portion of the body of the terminal. | 02-24-2011 |
| 20110124217 | CONNECTOR LOCKING DEVICE - Embodiments of the present invention relate to a connector locking device for network cables and methods of utilizing the same. In one embodiment of the present invention, a keyed-release connector locking device comprises a locking tongue support for supporting a locking tongue of a connector, the locking tongue of the connector consisting of a member biased about a front of the connector on a top surface thereof, extending towards a rear of the connector; a first retaining mechanism for engaging a portion of a body of a terminal, the body of the terminal comprising a structure having a housing on a top surface thereof for receiving the first retaining mechanism; and a key-accessible release arm for releasing the retaining mechanism from the portion of the body of the terminal when pivotably engaged. | 05-26-2011 |
Steven Foung, Stanford, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090041679 | HUMAN NEUTRALIZING MONOCLONAL ANTIBODIES TO H5N1 INFLUENZA A VIRUS - A panel of IgG | 02-12-2009 |
Steven K. H. Foung, Stanford, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090202482 | Prevention and Treatment of HCV Infection Employing Antibodies Directed Against Conformational and Linear Epitopes - Conformational epitopes of the envelope proteins E1 and E2 of the Hepatitis C virus (HCV) have been identified and characterized using a panel of monoclonal antibodies derived from patients infected with HCV. These conserved conformational and linear epitopes of the HCV protein E1 or E2 have been determined to be important in the immune response of humans to HCV and may be particularly important in neutralizing the virus. Based on the identification of these conformational epitopes, vaccines containing peptides and mimotopes with these conformational epitopes intact may be prepared and administered to patients to prevent and/or treat HCV infection. The identification of four distinct groups of monoclonal antibodies with each directed to a particular epitope of E1 or E2 may be used to stratify patients based on their response to HCV and may be used to determine a proper treatment regimen. Pharmaceutical compositions for prevention and treatment of HCV, comprising one or more the monoclonal antibodies, are provided. | 08-13-2009 |